Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Joseph Harvey

As Editor of Animal Pharm, Joseph Harvey provides news and analysis about the global animal health market across a range of species and products. He conducts exclusive interviews with the sector's biggest companies and experts, as well as start-up firms. He also hosts webinars and gives speeches on the industry.

Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.

Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Set Alert for Articles By Joseph Harvey

Latest From Joseph Harvey

Tropichem builds on North American foundations by expanding Canadian spot-on site

US contract development and manufacturing organization (CDMO) Tropichem Research Labs is building a non-sterile liquid facility in Montreal.

Operations R&D

Industry shows support for new FDA antimicrobial plan

Industry groups have generally expressed support for the US FDA's new antimicrobial resistance (AMR) strategy.

Antimicrobial resistance FDA

Carus Animal Health aims to fill animal welfare innovation gaps

Formed in 2017, Carus Animal Health is a UK-based business backed by Japan's largest animal health firm Kyoritsu Seiyaku. The new company has a mandate to stimulate innovation. Animal Pharm editor Joseph Harvey met Carus to explore its strategy for addressing unmet needs.

R&D Food Animals

Aratana begins developing AT-019 to build on EP4 base

Aratana Therapeutics is progressing R&D work on a candidate that targets the prostaglandin EP4 receptor.

Aratana Therapeutics R&D

US start-up seeks field trial partners for oral aqua vaccine

VakSea is in discussions with animal health companies concerning field trials in Asia of its natural immune-boosting protein derived from insect larva.

Aquaculture R&D

Animal Pharm Podcast #13: Anizome sheds light on the burgeoning animal microbiome opportunity

In this latest Animal Pharm podcast, editor Joseph Harvey finds out how addressing the microbiome is changing the way the animal health industry approaches R&D. To understand the potential of microbiome products, he spoke to Oliver Hardcastle – the chief executive of new firm Anizome.

Feed & Additives Companion Animals
See All